Concepedia

Debra Birnkrant

DB

Statistics

Publications

13

Citations

861

H-Index

12

Active since

2007

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Debra Birnkrant is an author at Center for Drug Evaluation and Research specializing in antiviral therapy, pharmacy, and infectious diseases.

Publications per year

2007–2023

13

Publications

13

The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza

Debra Birnkrant, Edward Cox · New England Journal of Medicine · 2009 · 185 citations · Full text

, , +8

Earlier Sustained Virologic Response End Points for Regulatory Approval and Dose Selection of Hepatitis C Therapies

Jianmeng Chen, Jeffry Florian, Wendy Carter et al. · Gastroenterology · 2013 · 172 citations

, , +16

Tecovirimat and the Treatment of Monkeypox — Past, Present, and Future Considerations

Adam Sherwat, John T. Brooks, Debra Birnkrant et al. · New England Journal of Medicine · 2022 · 171 citations

, , +6

Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System

Kirk M. Chan‐Tack, Melissa M. Truffa, Kimberly Struble et al. · AIDS · 2007 · 117 citations

, , +17

Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus

Alfred Sorbello, S. Christopher Jones, W. Carter et al. · Clinical Infectious Diseases · 2012 · 51 citations · Full text

, , +17

1–5 of 13